This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to the government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Centene is now a $100-billion plus enterprise catering healthcare services to more than 24 million members across 50 states. The recent acquisition of WellCare Health leveraged the company’s position as the largest Medicaid managed care organization in the country. The combined entity now has 22 million members. In 2019, the company retained its market-leading position nationwide, serving 1.8 million exchange members across 20 states at the year-end.
4 Health Insurance Companies in the Spotlight Right Now
by Zacks Equity Research
Based on a few positives, we narrowed down to four health insurers that deserve to be in your focus despite the COVID-19 crisis.
Is Centene (CNC) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why Is Centene (CNC) Down 0.7% Since Last Earnings Report?
by Zacks Equity Research
Centene (CNC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Humana, Healthmap Tie Up for Better Care to CKD Patients
by Zacks Equity Research
Humana (HUM) collaborates with Healthmap to offer better services to CKD patients in Florida.
Why Should You Retain Molina Healthcare in Your Portfolio?
by Zacks Equity Research
Riding high on its growing revenues and financial strength, Molina Healthcare (MOH) has potential to reap benefits to its investors.
UnitedHealth, Microsoft's New Mobile App to Help Trace Coronavirus
by Zacks Equity Research
UnitedHealth (UNH) and Microsoft will jointly launch a mobile application that will create a safe work ambience for employees returning to work by screening them for COVID-19 symptoms.
Why Should You Retain Anthem (ANTM) Stock in Your Portfolio?
by Zacks Equity Research
Banking on its sturdy membership and inorganic growth profile, Anthem (ANTM) holds potential to reap benefits for investors.
Humana (HUM) Rallies 59.3% in a Year: Further Upside Left?
by Zacks Equity Research
Humana's (HUM) solid Medicare business and inorganic growth story will likely boost its revenues, which in turn, might bump up its share price.
Are Investors Undervaluing Centene (CNC) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Tenet Healthcare (THC) Q1 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
Tenet Healthcare's (THC) Q1 results reflect a strong operating performance and an income tax benefit, partly offset by the coronavirus outbreak.
Molina Healthcare (MOH) Q1 Earnings Miss Mark, Slip Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) Q1 results reflect high expenses and low net income.
You Can Be a Value Investor and a Bull
by Tracey Ryniec
Waiting for the hot growth stocks to crash? Forget those and look for big cap bargains as the market heats up.
You Can Be a Value Investor and a Bull
by Tracey Ryniec
Waiting for the hot growth stocks to crash? Forget those and look for big cap bargains as the market heats up.
Anthem's (ANTM) Q1 Earnings Miss Estimates, Improve Y/Y
by Zacks Equity Research
Anthem's (ANTM) Q1 results reflect solid growth across Government Business, offset by weak performance of Commercial & Specialty Business and Other segments.
Company News for Apr 29, 2020
by Zacks Equity Research
Companies In The News Are: MMM, PEP, CNC, SIRI.
Centene's (CNC) Q1 Earnings Miss Estimates, Decline Y/Y
by Zacks Equity Research
Centene's (CNC) Q1 results reflect muted earnings due to lower investment income and incremental senior note interest expense.
Universal Health (UHS) Q1 Earnings, Revenues Miss Estimates
by Zacks Equity Research
Universal Health's (UHS) first-quarter earnings reflect pre-tax unrealized loss and higher expenses.
Centene (CNC) Q1 Earnings Lag Estimates
by Zacks Equity Research
Centene (CNC) delivered earnings and revenue surprises of -15.69% and 6.96%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Molina Healthcare's (MOH) Q1 Earnings: What's in Store?
by Zacks Equity Research
Molina Healthcare's (MOH) first-quarter results are likely to reflect lower membership, partly offset by better revenues.
Is a Surprise Coming for Centene (CNC) This Earnings Season?
by Zacks Equity Research
Centene (CNC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
What's in the Cards for Anthem's (ANTM) Earnings in Q1?
by Zacks Equity Research
Anthem's (ANTM) Q1 earnings results are likely to reflect higher revenues, backed by its Government and Commercial & Specialty businesses.
CNC vs. HUM: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CNC vs. HUM: Which Stock Is the Better Value Option?
What's in the Cards for Centene's (CNC) Earnings in Q1?
by Zacks Equity Research
Centene's (CNC) Q1 results are likely to reflect escalating expenses, partially offset by higher revenues.
Will Centene Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor Centene Corporation
Universal Health's (UHS) Q1 Earnings: What is in Store?
by Zacks Equity Research
Universal Health's (UHS) first-quarter results are likely to reflect better revenues, partially offset by the COVID-19 impact.